Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PHILLIP KUNISADA KIYASU

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1124010673
CMS profile
322489
Location
PORTLAND, OR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$181.29

3 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $155.59 2
Education $25.70 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PHILLIP KUNISADA KIYASU

NPI 1124010673 · CMS profile ID 322489

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

PORTLAND, OR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124010673?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PHILLIP KUNISADA KIYASU, NPI 1124010673, CMS profile ID 322489. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124010673?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). PHILLIP KUNISADA KIYASU, NPI 1124010673, CMS profile ID 322489. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124010673?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
PHILLIP KUNISADA KIYASU, NPI 1124010673, CMS profile ID 322489, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1124010673?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

3 matching records · $181.29 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 3 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–3 of 3.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $30.5910/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223923591 CMS
Janssen Scientific Affairs, LLC $125.0009/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174188756 CMS
Merck Sharp & Dohme LLC $25.7005/02/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1237995098 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $19.25 1
PY2024 $35.32 1
PY2025 $181.29 3

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $176,619.14 77
PY2024 Principal investigator $162,757.47 113
PY2023 Principal investigator $137,395.30 56
PY2022 Principal investigator $8,085.15 7
PY2021 Principal investigator $5,000.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

113 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $25.00 12/24/2024 Non-covered Recipient Entity
The Oregon Clnc
78934804CRD2001 No dispute reported 06/30/2026 1078976509
Principal investigator 1 Janssen Research & Development, LLC $157.00 12/19/2024 Non-covered Recipient Entity
The Oregon Clnc
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976439
Principal investigator 1 Janssen Research & Development, LLC $217.00 12/13/2024 Non-covered Recipient Entity
The Oregon Clnc
78934804CRD2001 No dispute reported 06/30/2026 1078976429
Principal investigator 1 Janssen Research & Development, LLC $50.00 12/13/2024 Non-covered Recipient Entity
The Oregon Clnc
78934804CRD2001 No dispute reported 06/30/2026 1078976479
Principal investigator 1 Janssen Research & Development, LLC $200.00 12/13/2024 Non-covered Recipient Entity
The Oregon Clnc
78934804CRD2001 No dispute reported 06/30/2026 1078976619
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 12/06/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125500344
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 12/06/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125500346
Principal investigator 1 Janssen Research & Development, LLC $3,553.00 12/02/2024 Non-covered Recipient Entity
The Oregon Clnc
78934804CRD2001 No dispute reported 06/30/2026 1078976399
Principal investigator 1 Janssen Research & Development, LLC $3,250.00 12/02/2024 Non-covered Recipient Entity
The Oregon Clnc
78934804CRD2001 No dispute reported 06/30/2026 1078976573
Principal investigator 1 Janssen Research & Development, LLC $157.00 11/27/2024 Non-covered Recipient Entity
The Oregon Clnc
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976405
Principal investigator 1 Janssen Research & Development, LLC $1,435.00 11/27/2024 Non-covered Recipient Entity
The Oregon Clnc
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976487
Principal investigator 1 Janssen Research & Development, LLC $880.00 11/21/2024 Non-covered Recipient Entity
The Oregon Clnc
78934804CRD2001 No dispute reported 06/30/2026 1078976417
Principal investigator 1 Janssen Research & Development, LLC $25.00 11/21/2024 Non-covered Recipient Entity
The Oregon Clnc
78934804CRD2001 No dispute reported 06/30/2026 1078976427
Principal investigator 1 Genentech, Inc. $470.73 11/13/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455193
Principal investigator 1 Genentech, Inc. $18.48 11/13/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455197
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 11/06/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125499252
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 11/06/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125499254
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 11/06/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125499256
Principal investigator 1 Janssen Research & Development, LLC $164.00 10/25/2024 Non-covered Recipient Entity
The Oregon Clnc
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976501
Principal investigator 1 Janssen Research & Development, LLC $50.00 10/25/2024 Non-covered Recipient Entity
The Oregon Clnc
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976547
Principal investigator 1 Janssen Research & Development, LLC $800.00 10/25/2024 Non-covered Recipient Entity
The Oregon Clnc
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976557
Principal investigator 1 Genentech, Inc. $4,418.00 10/09/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455189
Principal investigator 1 Janssen Research & Development, LLC $3,250.00 09/27/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976395
Principal investigator 1 Janssen Research & Development, LLC $343.00 09/27/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976409
Principal investigator 1 Janssen Research & Development, LLC $6,009.00 09/27/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976457
Principal investigator 1 Janssen Research & Development, LLC $25.00 09/27/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976551
Principal investigator 1 Janssen Research & Development, LLC $1,600.00 09/24/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976443
Principal investigator 1 Janssen Research & Development, LLC $157.00 09/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976407
Principal investigator 1 Janssen Research & Development, LLC $116.00 09/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976525
Principal investigator 1 Janssen Research & Development, LLC $325.00 09/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976537
Principal investigator 1 Janssen Research & Development, LLC $217.00 09/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976549
Principal investigator 1 Janssen Research & Development, LLC $1,920.00 09/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976559
Principal investigator 1 Janssen Research & Development, LLC $800.00 09/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976585
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $125.00 09/13/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125497495
Principal investigator 1 Janssen Research & Development, LLC $3,250.00 09/02/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976485
Principal investigator 1 Janssen Research & Development, LLC $3,990.00 09/02/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976513
Principal investigator 1 Janssen Research & Development, LLC $1,435.00 08/29/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976555
Principal investigator 1 Janssen Research & Development, LLC $101.00 08/26/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976543
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 08/12/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125495535
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 08/12/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125495537
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 08/12/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125495539
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 08/12/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125495541
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 08/12/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125495543
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 08/12/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125495545
Principal investigator 1 Janssen Research & Development, LLC $25.00 07/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976451
Principal investigator 1 Janssen Research & Development, LLC $274.00 07/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976493
Principal investigator 1 Janssen Research & Development, LLC $242.00 07/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976507
Principal investigator 1 Janssen Research & Development, LLC $250.00 07/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976515
Principal investigator 1 Janssen Research & Development, LLC $500.00 07/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976517
Principal investigator 1 Janssen Research & Development, LLC $4,259.00 07/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976599
Principal investigator 1 Janssen Research & Development, LLC $242.00 07/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976603
Principal investigator 1 Janssen Research & Development, LLC $880.00 07/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976623
Principal investigator 1 Janssen Research & Development, LLC $6,009.00 07/29/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976489
Principal investigator 1 Janssen Research & Development, LLC $3,250.00 07/29/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976531
Principal investigator 1 Janssen Research & Development, LLC $343.00 07/29/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976613
Principal investigator 1 Janssen Research & Development, LLC $242.00 07/29/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976615
Principal investigator 1 Genentech, Inc. $665.00 07/26/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455180
Principal investigator 1 Genentech, Inc. $1,128.75 07/26/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455185
Principal investigator 1 Janssen Research & Development, LLC $450.00 07/25/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976401
Principal investigator 1 Janssen Research & Development, LLC $153.00 07/25/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976447
Principal investigator 1 Janssen Research & Development, LLC $210.00 07/25/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976505
Principal investigator 1 Janssen Research & Development, LLC $270.00 07/25/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976539
Principal investigator 1 Janssen Research & Development, LLC $423.00 07/25/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976569
Principal investigator 1 Janssen Research & Development, LLC $800.00 07/25/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976611
Principal investigator 1 Janssen Research & Development, LLC $25.00 07/22/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976553
Principal investigator 1 Janssen Research & Development, LLC $157.00 07/17/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976419
Principal investigator 1 Janssen Research & Development, LLC $1,435.00 07/17/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976421
Principal investigator 1 Janssen Research & Development, LLC $2,720.00 07/17/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976511
Principal investigator 1 Janssen Research & Development, LLC $157.00 07/17/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976527
Principal investigator 1 Janssen Research & Development, LLC $157.00 07/17/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976561
Principal investigator 1 Janssen Research & Development, LLC $2,086.00 07/17/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976571
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,603.85 07/11/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 2/3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC GASTRITIS WITH OR WITHOUT EOSINOPHILIC DUODENITIS No dispute reported 06/30/2026 1082431218
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,570.00 07/11/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 2/3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC GASTRITIS WITH OR WITHOUT EOSINOPHILIC DUODENITIS No dispute reported 06/30/2026 1082431220
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $13,500.00 07/11/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 2/3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC GASTRITIS WITH OR WITHOUT EOSINOPHILIC DUODENITIS No dispute reported 06/30/2026 1082431222
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 07/08/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125493514
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 07/08/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125493516
Principal investigator 1 Janssen Research & Development, LLC $25.00 07/01/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976435
Principal investigator 1 Janssen Research & Development, LLC $50.00 07/01/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976453
Principal investigator 1 Janssen Research & Development, LLC $880.00 07/01/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976523
Principal investigator 1 Janssen Research & Development, LLC $3,772.00 06/28/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976591
Principal investigator 1 Janssen Research & Development, LLC $3,553.00 05/31/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976477
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 05/08/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125490807
Principal investigator 1 Janssen Research & Development, LLC $3,772.00 05/01/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976411
Principal investigator 1 Janssen Research & Development, LLC $210.00 05/01/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976415
Principal investigator 1 Janssen Research & Development, LLC $3,486.00 05/01/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976423
Principal investigator 1 Janssen Research & Development, LLC $210.00 05/01/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976431
Principal investigator 1 Janssen Research & Development, LLC $400.00 04/25/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976469
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $875.00 04/12/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489571
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489065
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489067
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489069
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489071
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489073
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489075
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489077
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489079
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489081
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $444.00 04/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1125489083
Principal investigator 1 Janssen Research & Development, LLC $4,049.00 03/28/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
78934804CRD2001 No dispute reported 06/30/2026 1078976607
Principal investigator 1 Janssen Research & Development, LLC $500.00 03/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976413
Principal investigator 1 Janssen Research & Development, LLC $800.00 03/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976473
Principal investigator 1 Janssen Research & Development, LLC $250.00 03/18/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976497
Principal investigator 1 Janssen Research & Development, LLC $822.00 03/13/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976449
Principal investigator 1 Janssen Research & Development, LLC $5,871.00 02/28/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976403
Principal investigator 1 Janssen Research & Development, LLC $50.00 02/28/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976455
Principal investigator 1 Genentech, Inc. $120.37 02/23/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455176
Principal investigator 1 Janssen Research & Development, LLC $1,435.00 02/12/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976577
Principal investigator 1 Janssen Research & Development, LLC $1,920.00 02/12/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976621
Principal investigator 1 Genentech, Inc. $170.12 02/07/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455165
Principal investigator 1 Genentech, Inc. $29,392.00 01/31/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455169
Principal investigator 1 Janssen Research & Development, LLC $50.00 01/24/2024 Non-covered Recipient Entity
Oregon Clnc PC Ste 735
CNTO1959CRD3004 No dispute reported 06/30/2026 1078976461
Principal investigator 1 Genentech, Inc. $205.17 01/05/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455173
Principal investigator 1 Genentech, Inc. $3,674.00 01/03/2024 Non-covered Recipient Entity
THE OREGON CLINIC PC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1133455161